Fang P, Yang J, Zhang H, Shuai D, Li M, Chen L
Front Oncol. 2025; 15:1506577.
PMID: 40071093
PMC: 11893407.
DOI: 10.3389/fonc.2025.1506577.
Chen X, Ju Q, Qiu D, Zhou Y, Wang Y, Zhang X
Cancer Immunol Immunother. 2025; 74(4):140.
PMID: 40056186
PMC: 11890711.
DOI: 10.1007/s00262-025-03996-3.
Du C, Sun D, Chen Y, Li J, Hong-Meng , Li C
BMC Cancer. 2025; 25(1):252.
PMID: 39948548
PMC: 11827470.
DOI: 10.1186/s12885-024-13385-1.
Zhang S, Huang J, Jiang Z, Tong H, Ma X, Liu Y
Mol Biomed. 2025; 6(1):9.
PMID: 39921821
PMC: 11807048.
DOI: 10.1186/s43556-025-00248-9.
Liu Y, Yang B, Qi Q, Liu S, Du Y, Ye L
Front Cell Infect Microbiol. 2025; 14:1518199.
PMID: 39916938
PMC: 11799255.
DOI: 10.3389/fcimb.2024.1518199.
16S rRNA sequencing reveals relationships among enrichment of oral microbiota in the lower respiratory tract and pulmonary nodules malignant progression.
Guo J, Han J, Li F, Ma Q, He J, You F
Microbiol Spectr. 2025; 13(3):e0128424.
PMID: 39907436
PMC: 11878090.
DOI: 10.1128/spectrum.01284-24.
Association between airway microbiota and systemic inflammation markers in non-small cell lung cancer patients.
Huang D, Ren Q, Xie L, Chen Y, Li C, Su X
Sci Rep. 2025; 15(1):3539.
PMID: 39875410
PMC: 11775180.
DOI: 10.1038/s41598-025-86231-4.
Characterizing microbial communities and their correlation with genetic mutations in early-stage lung adenocarcinoma: implications for disease progression and therapeutic targets.
Yang H, Zhang J, Feng H, Qi F, Kong F, Zhu W
Front Oncol. 2025; 14():1498524.
PMID: 39845316
PMC: 11752883.
DOI: 10.3389/fonc.2024.1498524.
A novel interplay between bacteria and metabolites in different early-stage lung cancer: an integrated microbiome and metabolome analysis.
Zhai X, Lin D, Shen Y, Zhai N, Yu F, Zhang J
Front Oncol. 2025; 14():1492571.
PMID: 39839794
PMC: 11746054.
DOI: 10.3389/fonc.2024.1492571.
Classification of NSCLC subtypes using lung microbiome from resected tissue based on machine learning methods.
Kashyap P, Raj K, Sharma J, Dutt N, Yadav P
NPJ Syst Biol Appl. 2025; 11(1):11.
PMID: 39824879
PMC: 11742043.
DOI: 10.1038/s41540-025-00491-4.
The Bidirectional Impact of Cancer Radiotherapy and Human Microbiome: Microbiome as Potential Anti-tumor Treatment Efficacy and Toxicity Modulator.
Palkovsky M, Modrackova N, Neuzil-Bunesova V, Liberko M, Soumarova R
In Vivo. 2024; 39(1):37-54.
PMID: 39740900
PMC: 11705129.
DOI: 10.21873/invivo.13803.
A scoring model based on bacterial lipopolysaccharide-related genes to predict prognosis in NSCLC.
Bao N, Zhang X, Lin C, Qiu F, Mo G
Front Genet. 2024; 15:1408000.
PMID: 39610830
PMC: 11602480.
DOI: 10.3389/fgene.2024.1408000.
Influence of gut and lung dysbiosis on lung cancer progression and their modulation as promising therapeutic targets: a comprehensive review.
Thapa R, Magar A, Shrestha J, Panth N, Idrees S, Sadaf T
MedComm (2020). 2024; 5(12):e70018.
PMID: 39584048
PMC: 11586092.
DOI: 10.1002/mco2.70018.
Crosstalk Between the Intratumoral Microbiota and the Tumor Microenvironment: New Frontiers in Solid Tumor Progression and Treatment.
Zhou Q, Zhou L, Chen X, Chen Q, Hao L
Cancer Rep (Hoboken). 2024; 7(11):e70063.
PMID: 39559964
PMC: 11574561.
DOI: 10.1002/cnr2.70063.
Air-Pollution-Mediated Microbial Dysbiosis in Health and Disease: Lung-Gut Axis and Beyond.
Mazumder M, Hussain S
J Xenobiot. 2024; 14(4):1595-1612.
PMID: 39449427
PMC: 11503347.
DOI: 10.3390/jox14040086.
Microbiota in tumors: new factor influencing cancer development.
Jiang H, Li L, Bao Y, Cao X, Ma L
Cancer Gene Ther. 2024; 31(12):1773-1785.
PMID: 39342031
DOI: 10.1038/s41417-024-00833-0.
Global research trends on the associations between the microbiota and lung cancer: a visualization bibliometric analysis (2008-2023).
Zhao M, Tian J, Hou W, Yin L, Li W
Front Microbiol. 2024; 15:1416385.
PMID: 39282557
PMC: 11392740.
DOI: 10.3389/fmicb.2024.1416385.
Microbiome-Stealth Regulator of Breast Homeostasis and Cancer Metastasis.
Furuta S
Cancers (Basel). 2024; 16(17).
PMID: 39272898
PMC: 11394247.
DOI: 10.3390/cancers16173040.
Oncogene-addicted solid tumors and microbiome-lung cancer as a main character: a narrative review.
Guardamagna M, Meyer M, Berciano-Guerrero M, Mesas-Ruiz A, Cobo-Dols M, Perez-Ruiz E
Transl Lung Cancer Res. 2024; 13(8):2050-2066.
PMID: 39263011
PMC: 11384476.
DOI: 10.21037/tlcr-24-216.
Unveiling microbial dynamics in lung adenocarcinoma and adjacent nontumor tissues: insights from nicotine exposure and diverse clinical stages via nanopore sequencing technology.
Yang K, Wang S, Ding Z, Zhang K, Zhu W, Wang H
Front Cell Infect Microbiol. 2024; 14:1397989.
PMID: 39258251
PMC: 11385298.
DOI: 10.3389/fcimb.2024.1397989.